Professor Kathy Pritchard-Jones is Chief Medical Officer for the UCLH Cancer Collaborative and London Cancer. Through these roles she has led the development of the London Cancer integrated cancer system, a new way of organising cancer care in north central and east London and west Essex, which focuses cancer care on the needs of the patient.
She is one of the UK’s foremost experts in childhood cancer, has been a consultant in the field for 20 years and is currently professor of paediatric oncology at the UCL Institute of Child Health and honorary consultant oncologist at Great Ormond Street NHS Foundation Trust.
She heads a laboratory for research into the molecular biology of childhood renal tumours, principally Wilms’ Tumour. Her group is researching improving risk stratification and more personalised treatment made possible by molecular medicine, to give children the best chance of a long-term cure without undue risky and potentially damaging side-effects.
Kathy plays a leading role in the activities of the International Society of Paediatric Oncology (SIOP) in Europe, including the development of a European Cancer Plan for children and adolescents and oversight of the SIOP Renal Tumours Study Group, responsible for clinical trials in childhood kidney cancers across Europe and further afield.